Parse Biosciences

Parse Biosciences is a life sciences company based in Seattle, Washington, founded in 2018 on research from the University of Washington. It develops a flexible, instrument-free single-cell sequencing platform intended to make single-cell analysis accessible to laboratories without the need for expensive proprietary instruments. The company reports that its technology is used in over 3,000 laboratories worldwide, and it supports experiments ranging from thousands to millions of cells.

The company's product line spans sample preparation through to data analysis. Evercode is an instrument-free single-cell sequencing and analysis technology platform that removes the requirement for specialised hardware. Trailmaker is the accompanying data analysis software, forming part of an end-to-end workflow. Technical work at the company covers molecular barcoding chemistry, genomics sample preparation and bioinformatics, with continuing development of its chemistry.

Parse Biosciences' technology is applied across life sciences research, including cancer research and treatment, tissue repair and regenerative medicine, stem cell therapy and immunology, as well as in academic and scientific research laboratories. From its Seattle origins the company has grown into a global supplier, with a stated mission of democratizing single-cell sequencing so that the technology is accessible to every lab.